News Release

Targeting Phage Therapy 2023: Where are we today and what's next?

Meeting Announcement

Mitochondria-Microbiota Task Force

6th World Congress on Targeting Phage Therapy 2023

image: The 6th World Congress on Targeting Phage Therapy 2023 will be held on June 1-2, in Paris, France. view more 

Credit: Credits to Targeting Phage Therapy Conference

The 6th World Congress on Targeting Phage Therapy 2023 has returned to present all aspects related to phages and phage therapy on June 1-2 in Paris, France.

It will highlight the recent innovations and clinical applications of phages, validation and limitations. Paris Targeting Phage Therapy 2023 will also cover how phage will transform the medicine of tomorrow.

International phage therapy and infectious disease experts will cover the following points:

  • Phage Therapy: Recent Advances & Challenges
  • Bacteriophage Characterization & Isolation
  • Co-Evolutionary Mechanisms of Bacteria and Phages
  • Bacteriophages & Microbiota: On the Way to a Medical Revolution?
  • Bacteriophage Prophylactic & Therapeutic Applications
  • Phages, Radiotherapy & Wound Healing


Bacteriophages & Microbiota: On the Way to a Medical Revolution?

In collaboration with the International Society of Microbiota (ISM), a session will be dedicated to how phage will modulate the quality and quantity of microbiota. We will also discuss how to select the adequate phage to target microbiota dysbiosis in disease.

Session Details.


Paris Targeting Phage Therapy 2023 Speakers

Targeting Phage Therapy 2023 will gather a group of academic and industrial professionals worldwide to discuss their most recent research and data.

Academic Speakers:

Domenico Frezza, University of Roma Tor Vergata, Italy

Phage Therapy: Vision and Gaps

Martha Clokie, University of Leicester, United Kingdom

Phage Therapy & Its Applications: Where We Are Now and What’s Next?

William Summers, Yale University, USA

 The History of Phage Therapy

Tristan Ferry, Hospices Civils de Lyon, France

The Use of Bacteriophage Therapy for Complex Bacterial Infections: the PHAGEinLYON Experience

Anna Pistocchi, Università degli Studi di Milano, Italy

Investigating the Therapeutic Potential of Phages as Antibacterials and Immunomodulators in a Zebrafish Model of Cystic Fibrosis

Rodrigo Ibarra Chavez, University of Copenhagen, Denmark

Phage-inducible Chromosomal Islands Promote Genetic Variability by Blocking Phage Reproduction

Lilian Musila, U.S. Army Medical Research Directorate, Kenya

Potential of Therapeutic Phages to Combat MDR ESKAPE Pathogens in Developing Nations

Jean-Paul Pirnay, Queen Astrid Military Hospital, Belgium

Bacteriophages: It’s a medicine, Jim, but not as we know it

Aleksandra Petrovic Fabijan, Westmead Institute for Medical Research, Australia

Therapeutic Monitoring of Phage Therapy

Noemi Poerio, University of Rome Tor Vergata, Italy

A Novel Combined Host- and Pathogen-Directed Therapeutic Approach to Fight Infections by MDR- Klebsiella pneumoniae

Ryszard Międzybrodzki, Hirszfeld Institute of Immunology and Experimental Therapy PAS, Poland

Phages in the Medical Research Activity in Poland

Anders S. Nilsson, Stockholm University, Sweden

Novel Computer Program for Modelling Bacteriophage Infection Kinetics

Farzaneh Moghtader, Istinye University, Turkey

Combined Therapies for Severely Infected Wounds: Multifunctional Bio-hybrids Composed of Gelatine Microspheres Carrying Bacteriophages and/or bFGF and their Aggregates with Mesenchymal Stem Cells

Willem-Jan Metsemakers, KU Leuven, Belgium

The Use of Bacteriophage Therapy for Difficult-to-Treat Musculoskeletal Infections: the PHAGEFORCE Experience

Mzia Kutateladze, Eliava Institute of Bacteriophage, Georgia

Phage Therapy: History in the Soviet Unions and Potential Treatment of Human Infections


Alexander Sulakvelidze, President and CEO of Intralytix, Inc., USA

Modern Approaches for Optimizing Therapeutic Phage Preparations

Jessica Sacher, cofounder of Phage Directory, Australia

Scaling Phage Therapy, Starting with Phage Australia

David Jernigan, PhagenCorp, LLC, USA

Inducing Native Phages From the Human Virome to Address Targeted Infections

Pranav Johri, Founder of Vitalis Phage Therapy, India

From Patient to Advocate – Introducing Phage Therapy to India


Present Your Innovations: 10 Minutes to Convince

During the Paris Targeting Phage Therapy 2023, a session will be dedicated to the latest innovations in the field of phages and phage therapy.

If you are academics, industrialists or representatives of startups, the scientific committee of Phage Therapy 2023 invites you to present your latest innovation in 10 minutes.

More information.

Tracks for abstract submission.

Abstract Submission Details.


Institutional Partners

This meeting is organized under the endorsement of the International Society of Microbiota (ISM).


Contact Us

In case you needed any further information on the registration, program, or abstract submission please visit our website.

You can also directly contact the organizing committee via email:

Find more information on our social media: LinkedIn and Facebook

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.